MedTrace Logo

Phase 2 Efficacy Trial of Z160 in Lumbosacral Radiculopathy

NCT01655849 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 141

Last updated 2013-12-12

No results posted yet for this study

Summary

This study will compare Z160 and placebo in patients with Lumbosacral Radiculopathy for safety and efficacy for a period of 6 weeks.

Conditions

  • Lumbosacral Radiculopathy

Interventions

DRUG

z160

DRUG

Placebo

Sponsors & Collaborators

  • Zalicus

    lead INDUSTRY

Principal Investigators

  • Margaret Lee, PhD · Zalicus Inc

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2013-10-31
Completion
2013-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01655849 on ClinicalTrials.gov